« All Events

CRISPR Solutions From Bench to Bedside – An IDT Lunch & Learn

Picture of the building exterior of the LMS Drug Discovery Hub, Imperial College London.

Join Integrated DNA Technologies at I-HUB to learn about the latest advances in CRISPR technology

In February 2025, Baby KJ was the first patient ever to receive a personalised, mRNA-based CRISPR therapy. With the help of IDT reagents and services, this custom CRISPR drug was designed, developed and manufactured in just 6 months.

Join IDT to learn about developments in:

  • gRNA design algorithms for knock-out screens
  • Design considerations for performing knock-ins
  • Peptide-based HDR enhancers
  • Off-target services for CRISPR safety assessment
  • … and plenty more!

Speaker:

Jennifer Stott: Field Applications Manager, EMEA